Wednesday - July 02, 2025

Category Archives: Europe

Fragile X Syndrome Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Zynerba Pharmaceuticals, Inc., Tetra Discovery Partners, Nova Mentis Life

Fragile X Syndrome Pipeline Analysis DelveInsight’s, “Fragile X Syndrome – Pipeline Insight, 2025,” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Fragile X Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading →

Follicular Lymphoma Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Mab Works, AstraZeneca, ADC Therapeutics,

Follicular Lymphoma Pipeline Insight DelveInsight’s, “Follicular Lymphoma – Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading →

Excessive Daytime Sleepiness Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Suven Life Sciences Limited, NLS Pharmaceutics, Axsome Therapeu

Excessive Daytime Sleepiness Pipeline Analysis DelveInsight’s, “Excessive Daytime Sleepiness – Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Excessive Daytime Sleepiness pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading →

Corneal Endothelial Dystrophy Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Trefoil Therapeutics, Aerie Pha

Corneal Endothelial Dystrophy Pipeline Analysis DelveInsight’s, “Corneal Endothelial Dystrophy – Pipeline Insight, 2025,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Corneal Endothelial Dystrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading →

Cystinosis Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | AVROBIO, Birch Therapeutics, Nacuity Pharmaceutica

Cystinosis Pipeline Analysis DelveInsight’s, “Cystinosis- Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cystinosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics … Continue reading →

Aneurysmal Subarachnoid Hemorrhage Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | BIT Pharma, Acasti Pharma

Aneurysmal Subarachnoid Hemorrhage Pipeline Analysis DelveInsight’s, “Aneurysmal Subarachnoid Hemorrhage Pipeline Insight, 2025,” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Aneurysmal Subarachnoid Hemorrhage (ASH) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical … Continue reading →

Alpha-1 Antitrypsin Deficiency Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Octapharma, Dicerna Pharmaceut

Alpha-1 Antitrypsin Deficiency Pipeline Insights DelveInsight’s, “Alpha1-Antitrypsin Deficiency (AATD) Pipeline Insight, 2025,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Alpha1-Antitrypsin Deficiency (AATD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage … Continue reading →

Warm Autoimmune Hemolytic Anemia (wAIHA) Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis

Warm Autoimmune Hemolytic Anemia (wAIHA) Pipeline Analysis Warm Autoimmune Hemolytic Anemia (wAIHA) companies are Fostamatinib, Immunovant Sciences GmbH, Apellis Pharmaceuticals, Inc., Bioverativ, and others. Warm Autoimmune Hemolytic Anemia (wAIHA) Pipeline constitutes 5+ key companies continuously working towards developing 5+ Warm … Continue reading →

Osteosarcoma Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | AlaMab Therapeutics, Zentalis Pharmaceuticals

Osteosarcoma pipeline insights Osteosarcoma companies are Isofol Medical, Merck, Eisai Co Ltd, Jiangsu Hengrui Medicine, AstraZeneca, Y-mAbs Therapeutics, Innovent Biologics, PersonGen BioTherapeutics (Suzhou), Cellectar Biosciences, Inc., MacroGenics, Shanghai Pharmaceuticals Holding, Celgene, Hutchmed, MedImmune LLC, Lee’s Pharmaceutical Limited, EMD Serono, Iovance … Continue reading →

Eosinophilic Esophagitis Treatment Market Size in the 7MM was ~USD 1,800 million in the 2023, which is expected to grow by 2034, estimates DelveInsight

DelveInsight’s “Eosinophilic Esophagitis Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Eosinophilic Esophagitis historical and forecasted epidemiology as well as the Eosinophilic Esophagitis market trends in the United States, EU4 (Germany, France, Italy, … Continue reading →